AAPS PharmSciTech

, Volume 4, Issue 4, pp 455–461 | Cite as

Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions

Article

Abstract

Water soluble compounds were incorporated into metered-dose inhalers (MDIs) by using water-in-propellant lecithin microemulsions, in which dimethyl ether (DME) and propane acted as both continuous phase and propellant. Lecithin, water, and water soluble compounds were added to glass MDI containers, valves were crimped on, and propellants were added using a pressure burette. Aerosols were produced using commercially available actuators, and inertial impaction was used to determine the mass median aerodynamic diameter (MMAD), geometric standard deviation (GSD), and fine particle fraction (FPF) of the resulting aerosols. The DME/propane/lecithin, microemulsion MDIs generated aerosols with particle size distributions suitable for pulmonary delivery (eg, MMAD 3.1 μm, FPF 59% for DME with lecithin content 3%, water content 2.5% [wt/wt]). Increasing water concentration (up to 8% wt/wt) was correlated with a reduction in FPF. Freezing and rewarming had no adverse effect on MMAD, GSD, or FPF. Storage of microemulsion samples for up to 3 weeks did not adversely affect the MMAD, GSD, or FPF. This approach may enable the pulmonary delivery of water soluble therapeutic agents via MDIs.

Keywords

microemulsion lecithin pulmonary dimethyl ether propane 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sommerville ML, Cain JB, Johnson CS, Hickey AJ. Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellants.Pharm Dev Technol. 2000;5(2): 219–230.CrossRefGoogle Scholar
  2. 2.
    Sommerville ML, Cain JB, Johnson CS, Rypacek F, Hickey AJ. Lecithin microemulsions in dimethylether and propane for the generation of pharmaceutical aerosols containing polar solutes.Pharm Dev Technol. 2002;7(3):273–288.CrossRefGoogle Scholar
  3. 3.
    Allen T. Particle size, shape, and distribution. In: Scarlett B, ed.Particle Size Measurement. 4th ed. New York, NY: Chapman and Hall Inc; 1990:124–189.Google Scholar
  4. 4.
    June DS, Schultz RK, Miller NC. A conceptual model for the development of pressurized metered-dose hydrofluroalkane-based inhalation aerosols.Pharm Tech. 1994;18:40–52.Google Scholar
  5. 5.
    Newman SP, Morén F, Pavia D, Corrado O, Clarke SW. The effects of changes in metered volume and propellant vapour pressure on the deposition of pressurized inhalation aerosols.Int J Pharm. 1982;11:337–344.CrossRefGoogle Scholar
  6. 6.
    Byron PR. Aerosol formulation, generation, and delivery using metered systems In: Byron PR, ed.Respiratory Drug Delivery. 1990:167–205.Google Scholar
  7. 7.
    Polli GP, Grim WM, Bacher FA, Yunker MH. Influence of formulation on aerosol particle size.J Pharm Sci. 1969;58:484–486.CrossRefGoogle Scholar
  8. 8.
    Gonda I. Development of a systematic theory of suspension inhalation aerosols. I. A framework to study the effects of aggregation on the aerodynamic behavior of drug particles.Int J Pharm. 1985;27:99–116.CrossRefGoogle Scholar
  9. 9.
    Pengilly RW, Keiner JA. The influence of some formulation variables and valve/actuator designs on the particle size distributions of aerosol sprays.J Soc Cosmet Chem. 1977;28:641–650.Google Scholar
  10. 10.
    Morén F. Drug deposition of pressurized inhalations aerosols. II. Influence of vapour pressure and metered volume.Int J Pharm. 1978;1:213–218.CrossRefGoogle Scholar
  11. 11.
    Vidgren MT, Paronen TP, Kärkkäinen A, Karjalainen P. Effect of extension devices on the drug deposition from inhalation aerosols.Int. J. Pharm. 1987;39:107–112.CrossRefGoogle Scholar
  12. 12.
    Evans RM, Farr SJ, Armstrong NA, Chatham SM. Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water.Pharm Res. 1991;8:629–634.CrossRefGoogle Scholar
  13. 13.
    Snell NJ, Ganderton D. Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research.Respir Med. 1999;93(2):123–133.CrossRefGoogle Scholar
  14. 14.
    Dunbar C.An Experimental and Theoretical Investigation of the Spray Issued From a Pressurized Metered-Dose Inhaler. [dissertation]. Manchester, UK: University of Manchester Institute of Science and Technology; 1996.Google Scholar
  15. 15.
    Dalby R, Byron PR. Comparison of output particle size distributions for pressurized aerosols formulated as solutions or suspensions.Pharm Res. 1988;5:36–39.CrossRefGoogle Scholar
  16. 16.
    Snead CC, Zung JT. The effects of insoluble films upon the evaporation kinetics of liquid droplets.J Colloid Interfacial Sci. 27:25–30.Google Scholar
  17. 17.
    Bohnenn LJM. Dimethylether pure: a review.Aerosol Age. 1981;(pt 2):42–47.Google Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2003

Authors and Affiliations

  1. 1.GlaxoSmithKline, IncResearch Triangle Park
  2. 2.School of PharmacyUniversity of North CarolinaChapel Hill

Personalised recommendations